https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Precipio%2C_Inc.Precipio, Inc. - Revizia istoricului2026-04-07T04:33:47ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Precipio,_Inc.&diff=436659&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Precipio, Inc. listata cu simbolurile US.PRPO, US.PRPOc ==Descriere companie== Precipio, Inc. (http://www.precipiodx.com/) is a cancer diagnostics and reagent technology company providing diagnostic products and services to the oncology market. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing...2024-09-18T18:22:45Z<p>Pagină nouă: Pagina dedicata companiei Precipio, Inc. listata cu simbolurile US.PRPO, US.PRPOc ==Descriere companie== Precipio, Inc. (http://www.precipiodx.com/) is a cancer diagnostics and reagent technology company providing diagnostic products and services to the oncology market. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Precipio, Inc. listata cu simbolurile US.PRPO, US.PRPOc<br />
<br />
==Descriere companie==<br />
Precipio, Inc. (http://www.precipiodx.com/) is a cancer diagnostics and reagent technology company providing diagnostic products and services to the oncology market. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing. IV-Cell is a media that enables culturing of all four hematopoietic cell lineages, which include myeloid cells, B-cells, T-cells and plasma cells. The diagnostic process of hematopoietic diseases involves chromosomal analysis by conducting cell-culture based tests by a cytogenetics laboratory to imitate in-vivo conditions. HemeScreen technology was developed by the Company targeting Myeloproliferative Neoplasms (MPN), which has evolved into a suite of robust genetic diagnostic panels. ICP technology was developed at Harvard and is licensed exclusively by Dana-Farber. The Company operate a cancer diagnostic laboratory located in New Haven.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.PRPO" /><br />
<iframe key="tradeville" path="graficSimbol/US.PRPOc" /><br />
<br />
==Ultimele stiri despre Precipio, Inc. (US.PRPO)==<br />
<dynamicpagelist><br />
category=US.PRPO<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
==Ultimele stiri despre Precipio, Inc. (US.PRPOc)==<br />
<dynamicpagelist><br />
category=US.PRPOc<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.PRPO]][[Categorie:US.PRPOc]][[Categorie:Stiri despre companii]]</div>Admin